GB Sciences, Inc. (OTCMKTS:GBLX – Get Free Report)’s share price passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.01 and traded as low as $0.00. GB Sciences shares last traded at $0.00, with a volume of 12,107 shares trading hands.
GB Sciences Price Performance
About GB Sciences
GB Sciences, Inc, a phytomedical research and biopharmaceutical drug development company, engages in the research and development of plant-based medicines. The company offers cannabinoid-inspired medicines and complex therapeutic mixtures for the prescription drug market. Its intellectual property covers a range of medical conditions and programs in pre-clinical animal stage for Parkinson's disease, neuropathic pain, chronic pain, COVID-related cytokine release syndrome, depression/anxiety, and cardiovascular therapeutic programs.
Recommended Stories
- Five stocks we like better than GB Sciences
- What is MarketRank™? How to Use it
- NVIDIA’s Hidden AI Play: The Truth Behind Its WeRide Investment
- Compound Interest and Why It Matters When Investing
- Up 50% in January, Twilio’s Pullback Is the Time to Buy
- Dividend Capture Strategy: What You Need to Know
- Watch These 3 Stocks—High Short Interest and Big Upside Potential
Receive News & Ratings for GB Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GB Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
